AGA Clinical Practice Guidelines on Intragastric Balloons in the Management of Obesity

      This document represents the official recommendations of the American Gastroenterological Association (AGA) and was developed by the AGA Clinical Guideline Committee and approved by the AGA Governing Board. Development of this guideline was fully funded by the AGA Institute with no additional outside funding.

      Abbreviations used in this paper:

      AGA (American Gastroenterological Association), BMI (body mass index), CI (confidence interval), GI (gastrointestinal), GRADE (Grading of Recommendations Assessment, Development and Evaluation), IGB (intragastric balloon), MD (mean difference), PICO (population, intervention, comparison, and patient-important outcomes), PPI (proton pump inhibitor), RCT (randomized controlled trial), RR (relative risk), SOC (standard of care), %TBWL (percent total body weight loss)
      To read this article in full you will need to make a payment
      AGA Member Login
      Login with your AGA username and password.
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Sultan S.
        • Falck-Ytter Y.
        • Inadomi J.M.
        The AGA institute process for developing clinical practice guidelines part one: grading the evidence.
        Clin Gastroenterol Hepatol. 2013; 11: 329-332
        • Shah R.
        • Davitkov P.
        • Abu Dayyeh B.K.
        • et al.
        AGA Institute Technical Review on Intragastric Balloons in the Management of Obesity.
        Gastroenterology. 2021; 160: 1811-1830
        • Benjamin S.B.
        • Maher K.A.
        • Cattau Jr., E.L.
        • et al.
        Double-blind controlled trial of the Garren-Edwards gastric bubble: an adjunctive treatment for exogenous obesity.
        Gastroenterology. 1988; 95: 581-588
        • Lindor K.D.
        • Hughes Jr., R.W.
        • Ilstrup D.M.
        • et al.
        Intragastric balloons in comparison with standard therapy for obesity—a randomized, double-blind trial.
        Mayo Clin Proc. 1987; 62: 992-996
        • Barkun A.N.
        • Almadi M.
        • Kuipers E.J.
        • et al.
        Management of nonvariceal upper gastrointestinal bleeding: guideline recommendations from the International Consensus Group.
        Ann Intern Med. 2019; 171: 805-822
        • Kherad O.
        • Restellini S.
        • Martel M.
        • et al.
        Proton pump inhibitors for upper gastrointestinal bleeding.
        Best Pract Res Clin Gastroenterol. 2019; 42–43: 101609
        • Koyyada A.
        Long-term use of proton pump inhibitors as a risk factor for various adverse manifestations.
        Pharmacovigilance. 2021; 76: 13-21
        • Mathieu N.
        [Risk of long-term treatment with proton pump inhibitors].
        Rev Prat. 2008; 58: 1451-1454
        • Thomson A.B.
        • Sauve M.D.
        • Kassam N.
        • et al.
        Safety of the long-term use of proton pump inhibitors.
        World J Gastroenterol. 2010; 16: 2323-2330
        • Abdelhamid S.A.
        • Kamel M.S.
        A prospective controlled study to assess the antiemetic effect of midazolam following intragastric balloon insertion.
        J Anaesthesiol Clin Pharmacol. 2014; 30: 383-386
        • Van Hee R.
        • Van Wiemeersch S.
        • Lasters B.
        • et al.
        Use of anti-emetics after intragastric balloon placement: experience with three different drug treatments.
        Obes Surg. 2003; 13: 932-937
        • Saif T.
        • Strain G.W.
        • Dakin G.
        • et al.
        Evaluation of nutrient status after laparoscopic sleeve gastrectomy 1, 3, and 5 years after surgery.
        Surg Obes Relat Dis. 2012; 8: 542-547
        • Wolf E.
        • Utech M.
        • Stehle P.
        • et al.
        Oral high-dose vitamin D dissolved in oil raised serum 25-hydroxy-vitamin d to physiological levels in obese patients after sleeve gastrectomy-a double-blind, randomized, and placebo-controlled trial.
        Obes Surg. 2016; 26: 1821-1829
        • Ruiz-Tovar J.
        • Llavero C.
        • Zubiaga L.
        • et al.
        Maintenance of Multivitamin supplements after sleeve gastrectomy.
        Obes Surg. 2016; 26: 2324-2330
        • Gehrer S.
        • Kern B.
        • Peters T.
        • et al.
        Fewer nutrient deficiencies after laparoscopic sleeve gastrectomy (LSG) than after laparoscopic Roux-Y-gastric bypass (LRYGB)—a prospective study.
        Obes Surg. 2010; 20: 447-453
        • Aarts E.O.
        • Janssen I.M.
        • Berends F.J.
        The gastric sleeve: losing weight as fast as micronutrients?.
        Obes Surg. 2011; 21: 207-211
        • Moore C.E.
        • Sherman V.
        Effectiveness of B vitamin supplementation following bariatric surgery: rapid increases of serum vitamin B12.
        Obes Surg. 2015; 25: 694-699
        • Capoccia D.
        • Coccia F.
        • Paradiso F.
        • et al.
        Laparoscopic gastric sleeve and micronutrients supplementation: our experience.
        J Obes. 2012; 2012: 672162
        • van Rutte P.W.
        • Aarts E.O.
        • Smulders J.F.
        • et al.
        Nutrient deficiencies before and after sleeve gastrectomy.
        Obes Surg. 2014; 24: 1639-1646
        • Damms-Machado A.
        • Friedrich A.
        • Kramer K.M.
        • et al.
        Pre- and postoperative nutritional deficiencies in obese patients undergoing laparoscopic sleeve gastrectomy.
        Obes Surg. 2012; 22: 881-889
        • Roman S.
        • Napoléon B.
        • Mion F.
        • et al.
        Intragastric balloon for "non-morbid" obesity: a retrospective evaluation of tolerance and efficacy.
        Obes Surg. 2004; 14: 539-544
        • Al-Momen A.
        • El-Mogy I.
        Intragastric balloon for obesity: a retrospective evaluation of tolerance and efficacy.
        Obes Surg. 2005; 15: 101-105
        • Farina M.G.
        • Baratta R.
        • Nigro A.
        • et al.
        Intragastric balloon in association with lifestyle and/or pharmacotherapy in the long-term management of obesity.
        Obes Surg. 2012; 22: 565-571
        • Angrisani L.
        • Lorenzo M.
        • Borrelli V.
        • et al.
        Is bariatric surgery necessary after intragastric balloon treatment?.
        Obes Surg. 2006; 16: 1135-1137
        • Abu Dayyeh B.K.
        • Kumar N.
        • Edmundowicz S.A.
        • et al.
        ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies.
        Gastrointest Endosc. 2015; 82: 425-438.e425
        • Neto M.G.
        • Silva L.B.
        • Grecco E.
        • et al.
        Brazilian Intragastric Balloon Consensus Statement (BIBC): practical guidelines based on experience of over 40,000 cases.
        Surg Obes Relat Dis. 2018; 14: 151-159
        • Byrd A.S.
        • Toth A.T.
        • Stanford F.C.
        Racial disparities in obesity treatment.
        Curr Obes Rep. 2018; 7: 130-138